Trastuget 440MG/VIAL
Trastuget 440 mg/Vial is a targeted cancer therapy containing trastuzumab, a monoclonal antibody used in the treatment of HER2-positive cancers. It is commonly prescribed for breast cancer and gastric (stomach) cancer where the tumor overexpresses the HER2 protein.
What is Trastuget 440 mg/Vial?
Trastuget 440 mg Injection is administered intravenously by healthcare professionals. It works by specifically targeting the HER2 receptors on cancer cells, helping to slow or stop their growth while minimizing damage to normal cells.
Uses of Trastuget 440 mg Injection
- Treatment of HER2-positive breast cancer
- Treatment of metastatic breast cancer
- Treatment of HER2-positive gastric cancer
- Used in combination with chemotherapy or as targeted therapy
Benefits of Trastuget 440 mg
- Targeted therapy with high precision against cancer cells
- Improves survival rates in HER2-positive cancers
- Reduces tumor growth and spread
- Can be used in early-stage and advanced cancers
- Often enhances the effectiveness of chemotherapy
How Trastuget Works
Trastuget contains trastuzumab, which binds to HER2 receptors on cancer cells. This blocks signals that promote cancer growth and also activates the immune system to destroy cancer cells.
Side Effects of Trastuget 440 mg/Vial
Common Side Effects
- Fever and chills (especially during infusion)
- Nausea and vomiting
- Fatigue
- Diarrhea
- Headache
Serious Side Effects
- Heart problems (cardiotoxicity)
- Lung issues (breathing difficulty)
- Severe infusion reactions
- Low white blood cell count
Precautions & Warnings
- Regular heart function monitoring is required
- Not safe during pregnancy (may harm the fetus)
- Use caution in patients with cardiac disease
- Administer only under medical supervision
Dosage & Administration
- Given as an intravenous (IV) infusion
- Dosage depends on body weight and treatment plan
- Administered by a trained healthcare provider in a clinical setting
Conclusion
Trastuget 440 mg/Vial is an advanced targeted therapy that plays a crucial role in treating HER2-positive cancers. Its precision-based mechanism makes it a vital option in modern oncology, though careful monitoring is essential due to potential side effects.